Search results
Found 31107 matches for
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
Srinivasa Rao Rao
MBBS, MS (res), DPhil, AFHEA Srinivasa Rao Rao - Senior Researcher in Cancer Genomics
Akira Wiberg
BA BM BCh DPhil FRCS(Plast) Akira Wiberg - Senior Clinical Research Fellow
Charlotte Bell
Charlotte Bell - Program Director – Industry Liaison in Experimental Medicine
Maria Navarro Perez
Maria Navarro Perez - Postdoctoral Research Assistant
Pak Hnag (Patrick) Wan
Pak Hnag (Patrick) Wan - Data Collection and Processing Assistant
Ioana Marian
MSc Ioana Marian - OCTRU Senior Medical Statistician